Natalizumab for relapsing multiple sclerosis

被引：0
|
作者：
Tenser, RB [1 ]
机构：
[1] Penn State Univ, Coll Med, Hershey, PA 17033 USA
来源：
NEW ENGLAND JOURNAL OF MEDICINE | 2006年 / 354卷 / 22期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：2387 / 2387
页数：1
相关论文
共 50 条
  • [31] Does natalizumab have a role in the treatment of relapsing multiple sclerosis?
    Martin Stangel
    Nature Clinical Practice Neurology, 2006, 2 : 476 - 477
  • [32] Natalizumab plus interferon beta-1a for relapsing multiple sclerosis
    Rudick, RA
    Stuart, WH
    Calabresi, PA
    Confavreux, C
    Galetta, SL
    Radue, EW
    Lublin, FD
    Weinstock-Guttman, B
    Wynn, DR
    Lynn, F
    Panzara, MA
    Sandrock, AW
    Fazekas, F
    Enzinger, C
    Seifert, T
    Storch, M
    Strasser-Fuchs, S
    Berger, T
    Dilitz, E
    Egg, R
    Deisenhammer, F
    Decoo, D
    Lampaert, J
    Bartholome, E
    Bier, J
    Stenager, E
    Rasmussen, M
    Binzer, M
    Shorsh, K
    Christensen, M
    Ravnborg, M
    Sorensen, PS
    Blinkenberg, M
    Petersen, B
    Hansen, HJ
    Bech, E
    Petersen, T
    Kirkegaard, M
    Eralinna, J
    Ruutiainen, J
    Soilu-Hänninen, M
    Säkö, E
    Laaksonen, M
    Reunanen, M
    Remes, A
    Keskinarkaus, I
    Moreau, T
    Noblet, M
    Rouaud, O
    Couvreur, G
    NEW ENGLAND JOURNAL OF MEDICINE, 2006, 354 (09): : 911 - 923
  • [33] Predicting the response status to natalizumab in relapsing-remitting multiple sclerosis
    Prosperini, L.
    Mancinelli, C. R.
    Gianni, C.
    Barletta, V.
    Fubelli, F.
    Borriello, G.
    Pozzilli, C.
    MULTIPLE SCLEROSIS JOURNAL, 2012, 18 : 469 - 470
  • [34] Natalizumab reduces loss of visual function in patients with relapsing multiple sclerosis
    Balcer, L
    Galetta, SL
    O'Connor, PW
    Havrdova, E
    Hutchinson, M
    Kappos, L
    Miller, DH
    Phillips, JT
    Polman, CH
    Stuart, WH
    Calabresi, PA
    Confavreux, C
    Radue, EW
    Rudick, RA
    Lublin, FD
    Giovannoni, G
    Wajgt, A
    Weinstock-Guttman, B
    Wynn, DR
    Lynn, FA
    Panzara, MA
    Sandrock, AW
    NEUROLOGY, 2006, 66 (05) : A251 - A251
  • [35] Natalizumab: A guide to its use in relapsing-remitting multiple sclerosis
    Keating G.M.
    McCormack P.L.
    Drugs & Therapy Perspectives, 2014, 30 (2) : 48 - 54
  • [36] Retrospective analysis of natalizumab switches to ublituximab in patients with relapsing multiple sclerosis
    Kutz, Christen
    MULTIPLE SCLEROSIS JOURNAL, 2024, 30 (03) : 1074 - 1075
  • [37] Reactivation of BK Virus during Natalizumab Therapy in Relapsing Multiple Sclerosis
    Lonergan, Roisin
    De Gascun, Cillian
    Carr, Michael
    Costelloe, Lisa
    Fletcher, Jean
    Coughlan, Suzie
    Waters, Aine
    Duggan, Marguerite
    Doyle, Katie
    Jordan, Sinead
    Hall, William W.
    Hutchinson, Michael
    Tubridy, Niall
    NEUROLOGY, 2009, 72 (11) : A34 - A34
  • [38] Clinical Course of Relapsing Remitting Multiple Sclerosis Post-Natalizumab
    Fiander, Maximillian D. J.
    Bhan, Virender
    Stewart, Samuel A.
    Parks, Natalie E.
    CANADIAN JOURNAL OF NEUROLOGICAL SCIENCES, 2019, 46 (04) : 455 - 458
  • [39] A randomized, placebo-controlled trial of natalizumab for relapsing multiple sclerosis
    Polman, CH
    O'Connor, PW
    Havrdova, E
    Hutchinson, M
    Kappos, L
    Miller, DH
    Phillips, JT
    Lublin, FD
    Giovannoni, G
    Wajgt, A
    Toal, M
    Lynn, F
    Panzara, MA
    Sandrock, AW
    NEW ENGLAND JOURNAL OF MEDICINE, 2006, 354 (09): : 899 - 910
  • [40] The efficacy of natalizumab in patients with relapsing multiple sclerosis: subgroup analyses of AFFIRM
    Havrdova, E
    O'Connor, P
    Hutchinson, M
    Kappos, L
    Miller, D
    Phillips, JT
    Polman, C
    Lublin, F
    Giovannoni, G
    Wajgt, A
    Lynn, F
    Toal, M
    Panzara, M
    Sandrock, A
    JOURNAL OF NEUROLOGY, 2005, 252 : 46 - 46
12345